Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. - Wikidata - awgldk - TriplyDB

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

http://www.wikidata.org/entity/Q40751631

about

Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF hTID-1 defines a novel regulator of c-Met Receptor signaling in renal cell carcinomas The MET axis as a therapeutic target.Recent developments in receptor tyrosine kinases targeted anticancer therapy Targeted drugs in small-cell lung cancer MET inhibitors in combination with other therapies in non-small cell lung cancer Tumor stroma as targets for cancer therapy Extracellular alkaline pH leads to increased metastatic potential of estrogen receptor silenced endocrine resistant breast cancer cells Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion MET molecular mechanisms and therapies in lung cancer Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC.SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro.Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.Geldanamycin and Its Derivatives Inhibit the Growth of Myeloma Cells and Reduce the Expression of the MET Receptor.NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases.Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer.Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.Targeted therapies in small cell lung cancer: a review Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.The role of the c-Met pathway in lung cancer and the potential for targeted therapy.MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines New metastatic model of human small-cell lung cancer by orthotopic transplantation in mice.Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression Molecular imaging of c-Met tyrosine kinase activity.Heat shock protein 90 inhibition in lung cancer.Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.Hsp90 and hepatobiliary transformation during sea lamprey metamorphosis.Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer.Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation.Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine.Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?c-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer.Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy

P2860

Q24306175-24CB9705-DC2E-45D1-8DEE-60E9EFBD37FF Q24337462-FCB71FCD-DA2A-4302-B29E-7C434FA67D7A Q24609682-EF4F7603-ED10-4E95-875E-7884B9D1F44E Q26751331-32221883-C911-4028-8A99-3DC7F00D839D Q26767017-A9F5A957-6F3F-4312-9058-C116AD6BD899 Q26823203-5FB090B1-7770-4723-84EA-7D6D603F883B Q27015980-D12FF11F-F139-4B1B-B8E2-7C3ABB3A55DD Q27304731-A0F0E583-DF2A-4CC3-B414-24F4F4CE526D Q27319440-3543B9C7-A96A-4790-84B8-F91E84E9D8BD Q27852235-2C578A50-446D-45FE-AAAA-98E57E767A11 Q28079245-C987952E-B659-407C-BDA8-C17D88E71470 Q28263339-6C158EAE-4907-4D54-962F-8A4135B71008 Q28272688-679FE577-FD30-4186-B941-FB76D9EB3E9B Q28534819-303512F3-91CF-4B62-B88B-FE287A6BD606 Q30428632-859C0F9C-F3AA-4391-A42A-05B547DAD67C Q33338267-30926D3F-3C46-4E8C-BAED-5F877958A856 Q33645244-509715E6-17F4-401B-B643-A39324F6C46B Q33789416-F17CC88F-505A-4000-ACC7-B739934C2A58 Q33834313-D528C437-F2AB-4124-981F-87A13806035E Q34013850-9E4AC186-A798-488B-996D-43B2096FA083 Q34493542-06811305-F52F-4A10-942B-E8CDAC42B3B2 Q35076234-1928D59F-C673-456E-83A8-7F0A4848869C Q35097581-9D2C6A25-997E-4051-B8E9-EC048346E853 Q35146597-663349E6-CBB7-47F3-AF4F-2045259D8260 Q35146937-5D368763-AD8C-44E8-B82A-1B636CB9A648 Q35208173-81BA1E1A-9A92-42F7-9BDC-80C7401A88CE Q35538433-5C6E52C8-2C84-4476-B84B-71F8D97E1E66 Q35677873-8ABE6DB5-B617-43F7-A4B2-99E7A746C923 Q35691515-3852C2F0-54CC-4C2B-BC69-46321E47FFC5 Q35762499-8C09431A-3492-46C3-A2B2-90D1A7E1E9AB Q35836427-DD701068-D840-49D8-A9B9-E1E760CA8757 Q35857968-7FDDE84A-7739-4895-961C-CA2D5843AC74 Q36092910-93119083-C812-42A1-9327-3FC6F4CA3668 Q36291482-D0842BC0-3499-446E-9BC7-59BA7E503D2F Q36335655-B573BD40-8570-4ADC-A7CA-A2011EB7D0EE Q36610910-4C1FA8BA-FE1E-4D96-A900-9778F5CD6A80 Q36621726-54737AB7-BA5E-4F57-A2BF-0B04C78A7898 Q36811784-0CA7CD79-7FF9-4AE1-9616-940D0FB6C045 Q36812161-0B4FB07E-9EDC-4868-AA14-3CE116ADE36C Q36828371-60D1C112-FB71-4808-B570-75EDDB2A257F

P2860

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

http://www.wikidata.org/entity/Q40751631

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

@en

type

label

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

@en

prefLabel

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

@en

P1433

Q40751631-9DB7569F-8B93-4B81-9E0D-621F81CB9A74

P1476

Q40751631-DEEC8E80-F76B-46B5-9E0D-265D8B1583F4

P2093

Q40751631-0455979D-6A9E-4310-AFE9-EB0E33CC4741

Q40751631-0FB157E7-2C90-4317-97F4-BC4CE1B3953F

Q40751631-31E9A665-58F3-4F23-81D6-03B36A49317E

Q40751631-4289254F-0ADE-4929-9EF6-F8B5A2585D7A

Q40751631-57A6E82A-3A23-40C3-B375-A7EE24128A29

Q40751631-58B65D9C-06C3-4649-85A2-8AE41EDA7647

Q40751631-670AA640-1A94-4DEA-A59F-40F364F96E5E

Q40751631-996E5A34-E2A8-4C60-A687-044F8FE33016

Q40751631-A8FC7D36-BB2D-4A15-ACB3-0398C55FB9A5

Q40751631-C9357A96-FCBB-4475-9925-448F1E2E334C

P304

Q40751631-528B8084-435C-4CA2-B47B-59E6416472D4

P31

Q40751631-90CFE19D-B5BB-474C-B7CA-F5562557D2AE

P407

Q40751631-2FEBA627-71B2-4930-8D76-2273F87E911B

P433

Q40751631-43EF6B43-DC1E-4490-A79C-4E62712E0CDC

P478

Q40751631-2259DC61-E404-46D7-8915-532411B0DEBA

P50

Q40751631-4AE2AA56-9341-499A-8D19-EEC8278B4AFB

P577

Q40751631-FD414A59-B03A-4C08-8AF8-F4FF3F511741

P698

Q40751631-106E65F9-04C1-4819-BC46-4C00DF56B1EF

P1433

Clinical Cancer Research

P1476

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer

@en

P2093

Bruce E Johnson

http://www.w3.org/2001/XMLSchema#string

Elena Tibaldi

http://www.w3.org/2001/XMLSchema#string

Erik Schaefer

http://www.w3.org/2001/XMLSchema#string

Gautam Maulik

http://www.w3.org/2001/XMLSchema#string

Geoffrey I Shapiro

http://www.w3.org/2001/XMLSchema#string

Jeffrey Lin

http://www.w3.org/2001/XMLSchema#string

Patrick C Ma

http://www.w3.org/2001/XMLSchema#string

Ravi Salgia

http://www.w3.org/2001/XMLSchema#string

Sudip K Ghosh

http://www.w3.org/2001/XMLSchema#string

Takashi Kijima

http://www.w3.org/2001/XMLSchema#string

P304

620-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11839685

http://www.w3.org/2001/XMLSchema#string